BIOMARKER:

EGFR A763_Y764insFQEA

Entrez ID:

Related biomarkers:

‹

›

EGFR A763_Y764insFQEA EGFR A763_Y764insFQEA	Lung Cancer Lung Cancer	gefitinib Sensitive: C3 – Early Trials
EGFR A763_Y764insFQEA EGFR A763_Y764insFQEA	Lung Cancer Lung Cancer	osimertinib Sensitive: C3 – Early Trials
EGFR A763_Y764insFQEA EGFR A763_Y764insFQEA	Lung Cancer Lung Cancer	afatinib Sensitive: C3 – Early Trials
EGFR A763_Y764insFQEA EGFR A763_Y764insFQEA	Lung Cancer Lung Cancer	erlotinib Sensitive: C3 – Early Trials
EGFR A763_Y764insFQEA EGFR A763_Y764insFQEA	Non Small Cell Lung Cancer NSCLC	erlotinib Sensitive: C4 – Case Studies
EGFR A763_Y764insFQEA EGFR A763_Y764insFQEA	Lung Adenocarcinoma LUAD	osimertinib Sensitive: D – Preclinical
EGFR A763_Y764insFQEA EGFR A763_Y764insFQEA	Lung Adenocarcinoma LUAD	afatinib Sensitive: D – Preclinical
EGFR A763_Y764insFQEA EGFR A763_Y764insFQEA	Lung Adenocarcinoma LUAD	erlotinib Sensitive: D – Preclinical
EGFR A763_Y764insFQEA EGFR A763_Y764insFQEA	Non Small Cell Lung Cancer NSCLC	afatinib Sensitive: D – Preclinical
EGFR A763_Y764insFQEA EGFR A763_Y764insFQEA	Non Small Cell Lung Cancer NSCLC	dacomitinib Sensitive: D – Preclinical
EGFR A763_Y764insFQEA EGFR A763_Y764insFQEA	Non Small Cell Lung Cancer NSCLC	osimertinib Sensitive: D – Preclinical